<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Torii Labs LLC

    Torii Labs LLC

    The company creates herbal tonics to balance and build bodies and minds. Torii Lab...

    The company creates herbal tonics to balance an...

    Fundraising Status:    EC
    Filing Type:    CF
    Cyndescope, Inc.

    Cyndescope, Inc.

    Cyndescope Inc. is a technology company focusing on software solutions for the hea...

    Cyndescope Inc. is a technology company focusin...

    Fundraising Status:    EC
    Filing Type:    CF
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    ICU Medical, Inc.

    ICU Medical, Inc.

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medica...

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manuf...

    Filing Type:    PU
    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    NanoString Technologies, Inc.

    NanoString Technologies, Inc.

    NanoString Technologies is a leading provider of life science tools for translatio...

    NanoString Technologies is a leading provider o...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.